You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

DEXTROMETHORPHAN POLISTIREX - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for dextromethorphan polistirex and what is the scope of freedom to operate?

Dextromethorphan polistirex is the generic ingredient in two branded drugs marketed by Rb Hlth, Amneal, and Tris Pharma Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for dextromethorphan polistirex. Twenty-eight suppliers are listed for this compound.

Summary for DEXTROMETHORPHAN POLISTIREX
US Patents:0
Tradenames:2
Applicants:3
NDAs:3
Drug Master File Entries: 4
Finished Product Suppliers / Packagers: 28
Raw Ingredient (Bulk) Api Vendors: 37
Patent Applications: 1,952
What excipients (inactive ingredients) are in DEXTROMETHORPHAN POLISTIREX?DEXTROMETHORPHAN POLISTIREX excipients list
DailyMed Link:DEXTROMETHORPHAN POLISTIREX at DailyMed
Medical Subject Heading (MeSH) Categories for DEXTROMETHORPHAN POLISTIREX
Paragraph IV (Patent) Challenges for DEXTROMETHORPHAN POLISTIREX
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
DELSYM Extended-release Suspension dextromethorphan polistirex 30 mg/5 mL 018658 1 2009-01-12

US Patents and Regulatory Information for DEXTROMETHORPHAN POLISTIREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rb Hlth DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Tris Pharma Inc DEXTROMETHORPHAN POLISTIREX dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 091135-001 May 25, 2012 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal DEXTROMETHORPHAN POLISTIREX dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 203133-001 Jul 28, 2017 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DEXTROMETHORPHAN POLISTIREX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Rb Hlth DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 ⤷  Sign Up ⤷  Sign Up
Rb Hlth DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.